COMPANY
JUNO PHARMACEUTICALS CORP.
JUNO PHARMACEUTICALS CORP.: marketing authorisation holder for Daptomycin, Icatibant, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN FOR INJECTION (DIN 02511738), Cancelled Pre Market Regulator Health Canada |
|---|---|
| Icatibant | ICATIBANT INJECTION (DIN 02523337), Cancelled Pre Market Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.